CRINETICS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.62 USD | -1.52% |
|
+5.61% | +42.27% |
| 10/05 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
| 09/05 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -1.52% | +5.61% | +42.27% | +127.00% | +91.89% | 399.19Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CRNX Stock
- Charts Crinetics Pharmaceuticals, Inc.
- Comparison Chart